GOLGI MATRIX ASSEMBLY AND DISASSEMBLY IN THE CELL CYCLE
细胞周期中高尔基体基质的组装和拆卸
基本信息
- 批准号:8695730
- 负责人:
- 金额:$ 46.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntibodiesArchitectureAutoimmune DiseasesBindingBiochemicalBiologicalBiological AssayCell CycleCell Cycle ProgressionCell membraneCell physiologyCellsCellular biologyChoristomaCollaborationsComplexCrosslinkerDiabetes MellitusDiseaseEnzymesEukaryotic CellEventFamilyFunctional disorderGolgi ApparatusGrowth FactorGuanosine Triphosphate PhosphohydrolasesHormonesHuntington DiseaseIn VitroInterphaseIonsLifeLinkMalignant NeoplasmsMapsMass Spectrum AnalysisMembraneMembrane ProteinsMethodsMitosisMitoticModelingMolecularMolecular Biology TechniquesNatureNeurodegenerative DisordersNeurotransmittersNormal CellOrganellesPathogenesisPatternPhosphorylationPhysiologicalProcessProteinsProteomeProteomicsProtocols documentationRegulationResearch PersonnelRoleSNAP receptorSorting - Cell MovementStructureSystemTechniquesTechnologyTestingTumor Cell LineVirus DiseasesWorkbasecrosslinkdrug developmentglycosylationhuman diseasein vitro Assayin vivoinsightinstrumentnovelprotein protein interactionpublic health relevancereconstitutionresponsesecretion processsecretory proteintooltrafficking
项目摘要
DESCRIPTION (provided by applicant): The Golgi complex is a membrane-bound organelle that serves as a central unit for trafficking, glycosylation, sorting and processing of membrane and secretory proteins in all eukaryotic cells, including hormones, growth factors, antibodies and digestive enzymes. Alterations in Golgi structure and function have been associated with a variety of human diseases, including cancer, autoimmune disease, Huntington's and Alzheimer's diseases, and viral infections. Golgi fragmentation has been observed in many tumor cell lines and tissues, and aberrant glycosylation is a hallmark of cancer. A detailed dynamic model of normal Golgi structure formation and the relationship to its vital cellular function is required before its role in human disease can be understood. The unique Golgi architecture (flattened cisternae arranged into stacks) is believed to rely on the protein network associated with the Golgi, the "Golgi matrix". Very limited information is currently available on the composition and functions of the Golgi matrix. Based on the observation that the Golgi disassembles and reassembles during each cycle of cell division, we hypothesize that the Golgi matrix that generates and maintains the Golgi structure in interphase must be disassembled during mitosis and this process is regulated by extensive mitotic phosphorylation that disrupts protein-protein interactions. This collaboration between a Golgi researcher (Dr. Wang) and a biological mass spectrometry expert (Dr. Andrews) applies a systems approach to investigate the nature of the Golgi matrix by mapping its composition and assembly in the cell cycle and the relationship between phosphorylation and protein-protein interactions. We have developed an in vitro assay that reconstitutes the disassembly of Golgi during mitosis and its reassembly after mitosis. This allows us to prepare interphase and mitotic Golgi membranes of high quantity and high purity for proteomic quantitative analysis and to perform targeted interventional studies. We will use our novel proteomic protocols to quantify protein-protein interaction and protein phosphorylation events. Correlation analysis will allow us to link specific phosphorylation events with protein interactions in the Golgi matrix during the cell cycle, which can be validated and characterized in our in vitro assay. In this study, we will: 1) Use quantitative proteomics to analyze the components of the Golgi matrix in interphase and mitotic Golgi; 2) Identify protein-protein interactions in the Golgi matrix and membranes in interphase and mitosis by crosslinking and proteomic analysis; 3) Determine the role of phosphorylation on Golgi matrix assembly and disassembly as well as in protein-protein and protein-membrane interactions in vitro and in vivo. In vitro discoveries will be validated in intact cells using our new crosslinker as well as cell biology and biochemical techniques. These studies will provide new insights into the Golgi structure and function in normal cells and its dysfunction in disease states.
描述(由申请人提供):高尔基复合体是一种膜结合细胞器,作为所有真核细胞中膜和分泌蛋白(包括激素、生长因子、抗体和消化酶)运输、糖基化、分选和加工的中心单位。高尔基体结构和功能的改变与多种人类疾病有关,包括癌症、自身免疫性疾病、亨廷顿病和阿尔茨海默病以及病毒感染。在许多肿瘤细胞系和组织中都观察到高尔基体断裂,异常糖基化是癌症的标志。在了解高尔基体在人类疾病中的作用之前,需要建立正常高尔基体结构形成及其与其重要细胞功能的关系的详细动态模型。独特的高尔基体结构(排列成堆叠的扁平池)被认为依赖于与高尔基体相关的蛋白质网络,即“高尔基体矩阵”。目前有关高尔基体基质的组成和功能的信息非常有限。基于对高尔基体在细胞分裂的每个周期期间分解和重新组装的观察,我们假设在间期产生和维持高尔基体结构的高尔基体基质必须在有丝分裂期间分解,并且该过程受到破坏蛋白质的广泛有丝分裂磷酸化的调节。蛋白质相互作用。高尔基体研究员(王博士)和生物质谱专家(安德鲁斯博士)之间的合作应用系统方法通过绘制细胞周期中高尔基体的组成和组装以及磷酸化和磷酸化之间的关系来研究高尔基体基质的性质。蛋白质-蛋白质相互作用。我们开发了一种体外测定法,可以重建有丝分裂期间高尔基体的分解及其在有丝分裂后的重新组装。这使我们能够制备大量高纯度的间期和有丝分裂高尔基体膜,用于蛋白质组定量分析并进行有针对性的介入研究。我们将使用我们新颖的蛋白质组学方案来量化蛋白质-蛋白质相互作用和蛋白质磷酸化事件。相关分析将使我们能够将特定的磷酸化事件与细胞周期期间高尔基体基质中的蛋白质相互作用联系起来,这可以在我们的体外测定中进行验证和表征。在本研究中,我们将: 1)利用定量蛋白质组学分析间期和有丝分裂高尔基体中高尔基体基质的成分; 2) 通过交联和蛋白质组分析鉴定高尔基体基质和细胞膜在间期和有丝分裂中的蛋白质-蛋白质相互作用; 3) 确定磷酸化对高尔基体基质组装和分解以及体外和体内蛋白质-蛋白质和蛋白质-膜相互作用的作用。体外发现将使用我们的新交联剂以及细胞生物学和生化技术在完整细胞中得到验证。这些研究将为正常细胞中高尔基体的结构和功能及其在疾病状态下的功能障碍提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip C Andrews其他文献
Enhanced antibacterial activity of dimethyl gallium quinolinolates toward drug-resistant Klebsiella pneumoniae in low iron environments.
在低铁环境中,二甲基喹啉镓对耐药肺炎克雷伯菌的抗菌活性增强。
- DOI:
10.1016/j.jinorgbio.2023.112371 - 发表时间:
2023 - 期刊:
- 影响因子:3.9
- 作者:
Rebekah N. Duffin;Philip C Andrews - 通讯作者:
Philip C Andrews
Philip C Andrews的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip C Andrews', 18)}}的其他基金
Engineered Nanodiscs for Structural Mass Spectrometry
用于结构质谱分析的工程纳米圆盘
- 批准号:
10033678 - 财政年份:2020
- 资助金额:
$ 46.65万 - 项目类别:
Engineered Nanodiscs for Structural Mass Spectrometry
用于结构质谱分析的工程纳米圆盘
- 批准号:
10267695 - 财政年份:2020
- 资助金额:
$ 46.65万 - 项目类别:
Engineered Nanodiscs for Structural Mass Spectrometry
用于结构质谱分析的工程纳米圆盘
- 批准号:
10460573 - 财政年份:2020
- 资助金额:
$ 46.65万 - 项目类别:
Exploration of Molecular Chaperone Complexes During Active Protein Triage
活性蛋白分类过程中分子伴侣复合物的探索
- 批准号:
8853890 - 财政年份:2014
- 资助金额:
$ 46.65万 - 项目类别:
Exploration of Molecular Chaperone Complexes During Active Protein Triage
活性蛋白分类过程中分子伴侣复合物的探索
- 批准号:
9229044 - 财政年份:2014
- 资助金额:
$ 46.65万 - 项目类别:
Exploration of Molecular Chaperone Complexes During Active Protein Triage
活性蛋白分类过程中分子伴侣复合物的探索
- 批准号:
9024586 - 财政年份:2014
- 资助金额:
$ 46.65万 - 项目类别:
GOLGI MATRIX ASSEMBLY AND DISASSEMBLY IN THE CELL CYCLE
细胞周期中高尔基体基质的组装和拆卸
- 批准号:
8902211 - 财政年份:2014
- 资助金额:
$ 46.65万 - 项目类别:
GOLGI MATRIX ASSEMBLY AND DISASSEMBLY IN THE CELL CYCLE
细胞周期中高尔基体基质的组装和拆卸
- 批准号:
9099899 - 财政年份:2014
- 资助金额:
$ 46.65万 - 项目类别:
New Structural Mass Spectrometry Tools Applied to the Mitochondrial Membrane Prot
新的结构质谱工具应用于线粒体膜保护
- 批准号:
8480422 - 财政年份:2013
- 资助金额:
$ 46.65万 - 项目类别:
New Structural Mass Spectrometry Tools Applied to the Mitochondrial Membrane Prot
应用于线粒体膜保护的新型结构质谱工具
- 批准号:
8690922 - 财政年份:2013
- 资助金额:
$ 46.65万 - 项目类别:
相似国自然基金
I型干扰素通路在抗MDA5抗体阳性皮肌炎相关间质性肺疾病中的作用和机制研究
- 批准号:82302020
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
缺氧通过HIF1α/TXNDC5通路调控IgG4相关性疾病B细胞分化及抗体类别转换重组
- 批准号:82302028
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向gp350/CD89的双特异抗体对EB病毒感染及EBV相关淋巴增殖性疾病的免疫治疗研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
吲哚丙烯酸对MOG抗体相关疾病小胶质细胞激活和神经炎症的调控及临床意义
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
神经胶质细胞抗体相关疾病对利妥昔单抗反应的差异性及其机制探究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 46.65万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 46.65万 - 项目类别:
Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function
阿尔茨海默病和唐氏综合症中 APP 拷贝数变异对 Reelin 表达和功能的影响
- 批准号:
10760161 - 财政年份:2023
- 资助金额:
$ 46.65万 - 项目类别:
The convergence of stress and sex on Abeta and tau metabolism and pathology
压力和性对 Abeta 和 tau 代谢及病理学的影响
- 批准号:
10734280 - 财政年份:2023
- 资助金额:
$ 46.65万 - 项目类别:
Evaluating a novel, orally-active TREM2-targeting drug in AD
评估一种新型口服活性 TREM2 靶向药物治疗 AD 的效果
- 批准号:
10735206 - 财政年份:2023
- 资助金额:
$ 46.65万 - 项目类别: